IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Feb 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-18

Reporting Person: MCKEON BRIAN P (Executive VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-18	Common Stock	M	1474	$67.85	Acquired	26188	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-18	Incentive Stock Option (right-to-buy)	$67.85	M	1474	Disposed	2026-02-13	Common Stock (1474)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18050	Indirect

Footnotes

F1: Grant of option to buy 4,395 shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on February 14, 2021.

F2: Not applicable.